Lineage, Inc. logo LINE - Lineage, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 10
SELL 3
STRONG
SELL
0
| PRICE TARGET: $38.29 DETAILS
HIGH: $41.00
LOW: $35.00
MEDIAN: $39.00
CONSENSUS: $38.29
DOWNSIDE: 8.20%

Stock News

Linear Announces Acquisition, Share Consolidation and Private Placement

Linear Announces Acquisition, Share Consolidation and Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / Linear Minerals Corp. (CSE:LINE)(OTC:LINMF)(WKN:A40Y3E) ("Linear" or the "Company") is pleased to announce that it has entered into a letter of intent (the "LOI") outlining its intention to acquire (the "Transaction") the Mooney Lake Uranium Project, the Hatsoff Tungsten-Molybdenum Project and the Gorge Lithium Project (collectively, the "Properties") via the acquisition of all of the issued and outstanding shares of Critical Prospecting Corp. ("Critical Prospecting"), the current owner of the Properties. Under the terms of the LOI, Linear will acquire all of the issued and outstanding securities of Critical Prospecting in exchange for the issuance of 4,788,000 Post-Consolidation Shares (as defined below) at a price of $0.25 per Post-Consolidation Share for a total purchase price of $1,197,000.

May 21, 2026 12:15 PM accessnewswire.com
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today reported its first quarter 2026 financial and operating results. The Company will host a conference call today at 4:30 p.m. Eastern Time to discuss these results and to provide a business update. “This quarter, we continued to build on our developmental and clinical acc.

May 12, 2026 12:01 PM businesswire.com
Lineage, Inc. Reports First-Quarter 2026 Financial Results

Lineage, Inc. Reports First-Quarter 2026 Financial Results

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced its financial results for the first quarter of 2026. First-Quarter 2026 Financial Highlights Total revenue increased 0.4% to $1,297 million GAAP net loss of $(51) million, or $(0.18) per diluted common share Adjusted EBITDA increased 3.3% to $314 million; adjusted EBITDA margin increased 70bps to 24.2% AFFO decreased (8.2)% to $201 million.

May 06, 2026 02:00 AM businesswire.com
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026

Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today announced that it will report its first quarter 2026 financial and operating results on Thursday, May 12, 2026, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on Thursday, May 12, 2026, at 4:30 p.m. Eas.

May 05, 2026 04:00 AM businesswire.com
Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm

NEW YORK, April 20, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Lineage, Inc. (NASDAQ: LINE) breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Lineage caused the company to misrepresent or fail to disclose that Lineage's financial and operational results had been temporarily inflated leading up to the IPO as a result of artificial market distortions caused by the COVID-19 pandemic, increased supply of cold-storage facilities, and the imposition of unsustainable price increases by Lineage.

Apr 20, 2026 04:26 AM prnewswire.com (Hide legal announcements)
Lineage Announces Formation of Scientific Advisory Board

Lineage Announces Formation of Scientific Advisory Board

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced the formation of a Scientific Advisory Board (SAB) to provide strategic counsel and insights into the development of Lineage's novel cell transplant pipeline, built on the Company's proprietary cell differentiation and expansion platform, AlloSCOPE™.

Apr 13, 2026 04:00 AM businesswire.com
A Fragile Truce

A Fragile Truce

U.S. equity markets extended their rebound this week as investors welcomed tentative progress toward de-escalation in the Middle East following several days of dramatic threats of significant escalation. The fragile pause in hostilities temporarily eased fears of a prolonged disruption to global energy supplies and fueled a sharp retreat in oil prices after a surge to four-year highs. Markets also found support from lukewarm inflation data and signs that the U.S. labor market continues to demonstrate resilience despite elevated energy costs and geopolitical uncertainty.

Apr 12, 2026 05:00 AM seekingalpha.com
Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Lineage, Inc. to Contact Law Firm

New York, New York--(Newsfile Corp. - April 9, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Lineage, Inc. (NASDAQ: LINE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Lineage caused the company to misrepresent or fail to disclose that Lineage's financial and operational results had been temporarily inflated leading up to the IPO as a result of artificial market distortions caused by the COVID-19 pandemic, increased supply of cold-storage facilities, and the imposition of unsustainable price increases by Lineage.

Apr 09, 2026 04:59 AM newsfilecorp.com (Hide legal announcements)
Lineage, Inc. Announces Chief Information Officer and Chief Transformation Officer Retirement and Transition Plan

Lineage, Inc. Announces Chief Information Officer and Chief Transformation Officer Retirement and Transition Plan

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (“Lineage” or the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced the planned retirement of its Chief Information Officer and Chief Transformation Officer, Sudarsan Thattai. The Company will implement a phased transition to maintain momentum across mission-critical initiatives and provide a smooth and well-supported leadership handoff. Thattai will continue his role as Chief Transformation O.

Apr 09, 2026 04:15 AM businesswire.com
Don't Put All Your REIT Eggs In One Basket

Don't Put All Your REIT Eggs In One Basket

REITs deserve a larger allocation today, driven by attractive valuations, structural demand, and reliable income across diverse sectors. Data center REITs like Equinix, Digital Realty, and Iron Mountain benefit from AI and cloud-driven demand, with strong growth and supply scarcity. Industrial REITs such as Prologis, EastGroup, and STAG Industrial offer structural growth, with EastGroup favored for its Sunbelt focus and robust internal growth.

Apr 05, 2026 06:05 AM seekingalpha.com
Lineage to Report First-Quarter 2026 Financial Results on May 6, 2026

Lineage to Report First-Quarter 2026 Financial Results on May 6, 2026

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) announced that it will report its financial results for the first quarter of 2026 on Wednesday, May 6, 2026, before market open. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Wednesday, May 6, 2026. A live webcast of the call will be available on the Lineage Investor Relations website at ir.onelineage.com. An audio replay of the conference call will be available for one week following the ca.

Apr 02, 2026 12:15 PM businesswire.com
NORWEGIAN CRUISE LINE® CHRISTENS THE STUNNING NORWEGIAN LUNA™ - THE NEWEST SHIP TO SAIL TO THE CARIBBEAN AND THE BAHAMAS FROM MIAMI

NORWEGIAN CRUISE LINE® CHRISTENS THE STUNNING NORWEGIAN LUNA™ - THE NEWEST SHIP TO SAIL TO THE CARIBBEAN AND THE BAHAMAS FROM MIAMI

– Norwegian Luna to Offer Round–Trip Caribbean Cruises Through April 2027 Visiting NCL's Beautiful Resort-Style Destinations, Great Stirrup Cay, Bahamas and Harvest Caye, Belize – – NCL's Newest Vessel Boasts Family-Friendly Activities for All, Including the Longest and Fastest Slides at Sea – MIAMI, March 30, 2026 /PRNewswire/ -- Norwegian Cruise Line® (NCL), the innovator in global cruise travel, celebrated the christening of Norwegian Luna™ in Miami on March 27, 2026. As the latest ship in the Company's fleet, Norwegian Luna offers a wide range of onboard experiences for every type of traveler and be the newest ship to call to the Caribbean with itineraries that visit both of NCL's resort-style destinations, Great Stirrup Cay in the Bahamas and Harvest Caye in Belize.

Mar 30, 2026 04:00 AM prnewswire.com

Price Targets